Kenneth J. Widder's most recent trade in QuidelOrtho Corporation was a trade of 7,021 Common Stock done at an average price of $15.7 . Disclosure was reported to the exchange on Nov. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.74 per share. | 25 Nov 2025 | 7,021 | 41,087 (0%) | 0% | 15.7 | 110,511 | Common Stock |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 7,021 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale of securities on an exchange or to another person at price $ 27.81 per share. | 25 Nov 2025 | 4,026 | 37,061 (0%) | 0% | 27.8 | 111,965 | Common Stock |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,829 | 6,829 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 2,926 | 2,926 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 878 | 878 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 4,929 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,929 | 34,066 (0%) | 0% | 0 | Common Stock | |
| Evoke Pharma Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,187 | 8,207 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2025 | 512 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2025 | 512 | 28,984 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2025 | 153 | 29,137 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2025 | 153 | 0 | - | - | Restricted Stock Units (Premium ) | |
| Personalis Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Evoke Pharma Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2024 | 3,333 | 0 | - | - | Non-Qualified Stock Option | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.91 per share. | 19 Jul 2024 | 3,333 | 28,472 (0%) | 0% | 27.9 | 93,024 | Common Stock |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 2,416 | 25,139 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,416 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| Evoke Pharma Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,929 | 4,929 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 2,112 | 2,112 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 633 | 633 | - | - | Restricted Stock Units (Premium) | |
| Personalis Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2024 | 328 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2024 | 328 | 22,625 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2024 | 98 | 22,723 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2024 | 98 | 0 | - | - | Restricted Stock Units (Premium) | |
| Personalis Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,248 | 22,297 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 2,248 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 2,416 | 2,416 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 978 | 978 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 293 | 293 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2023 | 1,050 | 19,734 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2023 | 1,050 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2023 | 315 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2023 | 315 | 20,049 (0%) | 0% | 0 | Common Stock | |
| Evoke Pharma Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 2,248 | 2,248 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 910 | 910 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 273 | 273 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 18,684 | 18,684 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 18,684 | 0 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 7,021 | 7,021 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 7,021 | 7,021 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 7,021 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 7,021 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 5,065 | 5,065 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 5,065 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 3,333 | 3,333 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 3,333 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,050 | 1,050 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 1,050 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 512 | 512 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 512 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 328 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 328 | 328 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 315 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 315 | 315 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 153 | 153 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 153 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 98 | 98 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 98 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2022 | 791 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2022 | 791 | 16,823 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2022 | 237 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2022 | 237 | 17,060 (0%) | 0% | 0 | Common Stock | |
| Evoke Pharma Inc | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,624 | 1,624 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 512 | 512 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 153 | 153 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2021 | 576 | 16,032 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Kenneth J. Widder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2021 | 576 | 0 | - | - | Restricted Stock Units (Premium) |